BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin GN, Liu PP, Liu DY, Peng JW, Xiao JJ, Xia ZJ. Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy. Chin J Cancer 2016;35:5. [PMID: 26740116 DOI: 10.1186/s40880-015-0063-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Peng J, Li H, Ou Q, Lin J, Wu X, Lu Z, Yuan Y, Wan D, Fang Y, Pan Z. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival. Onco Targets Ther 2017;10:3789-99. [PMID: 28794643 DOI: 10.2147/OTT.S140872] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ciocan A, Ciocan RA, Al Hajjar N, Gherman CD, Bolboacă SD. Abilities of Pre-Treatment Inflammation Ratios as Classification or Prediction Models for Patients with Colorectal Cancer. Diagnostics (Basel) 2021;11:566. [PMID: 33801031 DOI: 10.3390/diagnostics11030566] [Reference Citation Analysis]
3 Cui M, Xu R, Yan B. A persistent high neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with colorectal cancer undergoing resection. Mol Clin Oncol 2020;13:63. [PMID: 32963782 DOI: 10.3892/mco.2020.2133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wen S, Chen N, Hu Y, Huang L, Peng J, Yang M, Shen X, Song Y, Xu L. Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression. Cancer Med 2021;10:1690-714. [PMID: 33591628 DOI: 10.1002/cam4.3773] [Reference Citation Analysis]
5 Yang XZ, Cui SZ, Zeng LS, Cheng TT, Li XX, Chi J, Wang R, Zheng XF, Wang HY. Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer. Aging (Albany NY) 2017;9:914-31. [PMID: 28316326 DOI: 10.18632/aging.101200] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
6 Peng J, Zhang R, Zhao Y, Wu X, Chen G, Wan D, Lu Z, Pan Z. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer. Chin J Cancer 2017;36:96. [PMID: 29268783 DOI: 10.1186/s40880-017-0260-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
7 Guo YH, Sun HF, Zhang YB, Liao ZJ, Zhao L, Cui J, Wu T, Lu JR, Nan KJ, Wang SH. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis. Oncotarget 2017;8:20011-24. [PMID: 28212553 DOI: 10.18632/oncotarget.15311] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
8 Wen S, Chen N, Peng J, Ling W, Fang Q, Yin SF, He X, Qiu M, Hu Y. Peripheral monocyte counts predict the clinical outcome for patients with colorectal cancer: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2019;31:1313-21. [PMID: 31567616 DOI: 10.1097/MEG.0000000000001553] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Song W, Wang K, Zhang RJ, Zou SB. Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: A meta-analysis. Medicine (Baltimore) 2016;95:e5540. [PMID: 27930549 DOI: 10.1097/MD.0000000000005540] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
10 Matsuoka H, Ando K, Hu Q, Zaitsu Y, Tsuda Y, Hisamatsu Y, Nakashima Y, Kimura Y, Oki E, Mori M. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer. Int J Clin Oncol 2020;25:1318-26. [PMID: 32279124 DOI: 10.1007/s10147-020-01672-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Mao Y, Chen D, Duan S, Zhao Y, Wu C, Zhu F, Chen C, Chen Y. Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis. Cancer Cell Int 2018;18:201. [PMID: 30534002 DOI: 10.1186/s12935-018-0698-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
12 Wu Q, Hu T, Zheng E, Deng X, Wang Z. Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: An up-to-date meta-analysis. Medicine (Baltimore) 2017;96:e7051. [PMID: 28562566 DOI: 10.1097/MD.0000000000007051] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
13 Rossi S, Basso M, Strippoli A, Schinzari G, D'Argento E, Larocca M, Cassano A, Barone C. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? Clin Colorectal Cancer 2017;16:264-74. [PMID: 28412137 DOI: 10.1016/j.clcc.2017.03.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
14 Pletcher E, Gleeson E, Shaltiel T, Leigh N, Sullivan B, Labow D, Magge D, Golas B, Cohen N, Sarpel U. Lymphocyte-to-monocyte ratio predicts survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Biomark Med 2021;15:965-75. [PMID: 34289740 DOI: 10.2217/bmm-2020-0720] [Reference Citation Analysis]
15 Wang Y, Yuan YF, Lin HC, Li BK, Wang FH, Wang ZQ, Ding PR, Chen G, Wu XJ, Lu ZH, Pan ZZ, Wan DS, Sun P, Yan SM, Xu RH, Li YH. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases. Chin J Cancer. 2017;36:78. [PMID: 28969708 DOI: 10.1186/s40880-017-0244-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Huang Y, Li W, Quan Q, Zhang B, Yang Q. Glasgow PrognosticScore as a Predictor of BevacizumabEfficacy in the First-line Treatment with Metastatic Colorectal Cancer. J Cancer 2019;10:6858-64. [PMID: 31839820 DOI: 10.7150/jca.31182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]